Action,Not Rhetoric,Needed to Reverse the Opioid Overdose Epidemic

Abstract

Despite shifts in rhetoric and some positive movement, Americans with the disease of addiction are still often stigmatized, criminalized, and denied access to evidencebased care. Dramatically reducing the number of lives unnecessarily lost to overdose requires an evidence-based, equity-focused, well-funded, and coordinated response. We present in this brief article evidence-based and promising practices for improving and refocusing the response to this simmering public health crisis. Topics covered include improving clinical decision-making, improving access to non-judgmental evidence-based treatment, investing in comprehensive public health approaches to problematic drug use, and changing the way law enforcement actors interact with people who use drugs.

Get full access to this article

View all access options for this article.

References

Office of National Drug Control Policy, Epidemic: Responding to America's Prescription Drug Abuse Crisis (2011), Office of National Drug Control Policy.

Centers for Disease Control and Prevention, Number and Age-Adjusted Rates of Drug-Poisoning Deaths Involving Opioid Analgesics and Heroin: United States, 2000–2014 (2015).

Park and

Bloch , “How the Epidemic of Drug Overdose Death Ripples Across America,” New York Times, January 19, 2016.

McLean

, “There's Nothing Here”: Deindustrialization as Risk Environment for Overdose,” International Journal of Drug Policy no. 29 (2016): 19-26; K. M. Keyes, M. Cerda, J. E. Brady, J. R. Havens, and S. Galea, “Understanding the Rural-Urban Differences in Nonmedical Prescription Opioid Use and Abuse in the United States,” American Journal of Public Health 104, no. 2 (2014): e52-e59; A. Case and A. Deaton, “Rising Morbidity and Mortality in Midlife among White Non-Hispanic Americans in the 21st Century,” Proceedings of the Nationall Academy of Science 112, no. 49 (2015): 15078-15083; L. R. Webster, S. Cochella, N. Dasgupta, K. L. Fakata, P. G. Fine, S. M. Fishman, T. Grey, E. M. Johnson, L. K. Lee, S. D. Passik, J. Peppin, C. A. Porucznik, A. Ray, S. H. Schnoll, R. L. Stieg, and W. Wakeland, “An Analysis of the Root Causes for Opioid-Related Overdose Deaths in the United States,” Pain Medicine 12, Supp. 2 (2011): S26-35.

S. G.

Kertesz

, “Turning the Tide or Riptide? The Changing Opioid Epidemic,” Substance Abuse (November 18, 2016): 1-6.

Hedegaard ,

L. H.

Chen , and

Warner , “Drug-Poisoning Deaths Involving Heroin: United States, 2000-2013,” NCHS Data Brief 190 (2015):1-8.

T. C.

Green , and

Gilbert , “Counterfeit Medications and Fentanyl,” JAMA Intern Medicine 176, no. 10 (2016): 1557-1557.

Bourgois

, “Crack and the Political Economy of Social Suffering,” Addiction Research & Theory 11, no. 1 (2009): 31-37.

C. S.

Davis ,

T. C.

Green , and

N. D.

Zaller , “Addressing the Overdose Epidemic Requires Timely Access to Data to Guide Interventions,” Drug and Alcohol Review 35, no. 4 (2016): 383-386.

10.

Tsang ,

Von Korff ,

Lee ,

Alonso ,

Karam ,

M. C.

Angermeyer ,

G. L.

Borges ,

E. J.

Bromet ,

Demytteneare ,

de Girolamo ,

de Graaf ,

Gureje ,

J. P.

Lepine ,

J. M.

Haro ,

Levinson ,

M. A. Oakley

Browne ,

Posada-Villa ,

Seedat , and

Watanabe , “Common Chronic Pain Conditions in Developed and Developing Countries: Gender and Age Differences and Comorbidity with Depression-Anxiety Disorders,” Journal of Pain 9, no. 10 (2008): 883-891.

11.

Chiu ,

Davis , and

Burris , “Access to Therapeutic Opioids: A Plan of Action for Donors, NGOs, and Governments,” Temple International & Comparative Law Journal 24, no. 2 (2011): 101-130; G. Newshan and J. A. Staats, “Evidence-Based Pain Guidelines in HIV Care,” Journal of the Association of Nurses in AIDS Care 24, Supp. 1 (2013): S112-S126.

12.

G. M.

Franklin and the American Academy of Neurology, “Opioids for Chronic Noncancer Pain: A Position Paper of the American Academy of Neurology,” Neurology 83, no. 14 (2014): 1277-1284.

13.

Dowell ,

T. M.

Haegerich , and

Chou , “CDC Guideline for Prescribing Opioids for Chronic Pain–United States, 2016,” JAMA 315, no. 15 (2016): 1624-1645.

14.

Kolodny ,

D. T.

Courtwright ,

C. S.

Hwang ,

Kreiner ,

J. L.

Eadie ,

T. W.

Clark , and

G. C.

Alexander , “The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction,” Annual Review of Public Health 36 (2015): 559-574.

15.

Bernabei ,

Gambassi ,

Lapane ,

Landi ,

Gatsonis ,

Dunlop ,

Lipsitz ,

Steel , and

Mor , “Management of Pain in Elderly Patients with Cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology,” JAMA 279, no. 23 (1998): 1877-1882; S. H. Meghani, E. Byun, and R. M. Gallagher, “Time to Take Stock: A Meta-analysis and Systematic Review of Analgesic Treatment Disparities for Pain in the United States,” Pain Medicine 13, no. 2 (2012): 150-174.

16.

C. S.

Davis and

Carr , “Physician Continuing Education to Reduce Opioid Misuse, Abuse, and Overdose: Many Opportunities, Few Requirements,” Drug and Alcohol Dependence 163 (2016): 100-107.

17.

A. Y.

Walley ,

Xuan ,

H. H.

Hackman ,

Quinn ,

Doe-Simkins ,

Sorensen-Alawad ,

Ruiz , and

Ozonoff , “Opioid Overdose Rates and Implementation of Overdose Education and Nasal Naloxone Distribution in Massachusetts: Interrupted Time Series Analysis,” BMJ 346 (2013): f174.

18.

Substance Abuse and Mental Health Services Administration, Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings (2014);

C. S.

Davis and

Carr , “Legal Changes to Increase Access to Naloxone for Opioid Overdose Reversal in the United States,” Drug and Alcohol Dependence 157 (2015): 112-120.

19.

Rutkow and

C. S.

Davis , “Opportunities to Improve Decision-Making about Opioid Prescribing,” Journal of General Internal Medicine 32, no. 1 (2017): 3-5.

20.

Brody

, “Effective Addiction Treatment,” New York Times, February 4, 2013.

21.

Executive Office of the President, National Drug Control Strategy: FY 2016 Budget and Performance Summary (2015).

22.

S. A.

Strathdee ,

Beletsky , and

Kerr , “HIV, Drugs and the Legal Environment,” International Journal of Drug Policy 26, Supp. 1 (2015): S27-S32; C. S. Davis, S. Burris, J. Kraut-Becher, K. G. Lynch, and D. Metzger, “Effects of an Intensive Street-Level Police Intervention on Syringe Exchange Program Use in Philadelphia, PA,” American Journal of Public Health 95, no. 2 (2005): 233-236.

23.

Tempalski ,

P. L.

Flom ,

S. R.

Friedman ,

D. C.

Des Jarlais ,

J. J.

Friedman ,

McKnight , and

Friedman , “Social and Political Factors Predicting the Presence of Syringe Exchange Programs in 96 US Metropolitan Areas,” American Journal of Public Health 97, no. 3 (2007): 437-447.